Regenerative medicine in pain care includes platelet-rich plasma (PRP), prolotherapy, and selected cell-based approaches. Multiple systematic reviews have evaluated their use in conditions such as knee osteoarthritis, tendinopathy, and chronic musculoskeletal pain.
The current literature suggests that selected regenerative therapies may support pain reduction and functional improvement in carefully chosen patients. Effect sizes, durability, and cost-effectiveness vary by compound, preparation, and indication.
What this means for patients
- Regenerative care may be appropriate for some patients with specific musculoskeletal conditions.
- Patient selection, image guidance, and physician oversight strongly influence outcomes.
What this does not mean
- It does not mean regenerative therapies regenerate cartilage or reverse structural disease.
- It does not mean every patient with pain is a candidate.
Sources
- PubMed — PRP for knee osteoarthritis (systematic reviews)
Multiple systematic reviews and meta-analyses have evaluated PRP in knee osteoarthritis, reporting improvements in pain and function in selected patient populations.
- PubMed Central — Regenerative medicine in pain management
Reviews discuss the clinical evidence and limitations of regenerative therapies in chronic pain, emphasizing patient selection and conservative claims.
Regenerative and cell-based therapies are not appropriate for every patient or condition. Outcomes vary, and treatment should be considered only after a physician evaluation, diagnostic review, and discussion of risks, benefits, and alternatives.
Want to understand whether this applies to you?
Request a Private AssessmentHave imaging, labs, or prior treatment records?
Request a Private Assessment